Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Similar articles for PubMed (Select 23217184)

1.

An examination of pharmaceutical systems in severely disrupted countries.

Kohler JC, Pavignani E, Michael M, Ovtcharenko N, Murru M, Hill PS.

BMC Int Health Hum Rights. 2012 Dec 6;12:34. doi: 10.1186/1472-698X-12-34.

2.

Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.

Mackey TK, Liang BA, York P, Kubic T.

Am J Trop Med Hyg. 2015 Jun 3;92(6 Suppl):59-67. doi: 10.4269/ajtmh.14-0389. Epub 2015 Apr 20.

3.

Human resources for health in six healthcare arenas under stress: a qualitative study.

Durham J, Pavignani E, Beesley M, Hill PS.

Hum Resour Health. 2015 Mar 29;13:14. doi: 10.1186/s12960-015-0005-7.

4.

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change.

Babar ZU, Gray A, Kiani A, Vogler S, Ballantyne P, Scahill S.

J Pharm Policy Pract. 2014 Jul 8;7:8. doi: 10.1186/2052-3211-7-8. eCollection 2014. No abstract available.

5.

[Access to medicines and pharmaceutical market situation in Ecuador].

[No authors listed]

Rev Panam Salud Publica. 2014 Oct;36(4):281-2. Spanish. No abstract available.

6.

Regulated markets of kidneys in developed countries or how to increase health inequities.

Allard J, Goldberg A, Fortin MC.

Am J Bioeth. 2014;14(10):44-5. doi: 10.1080/15265161.2014.947442. No abstract available.

PMID:
25229586
7.

Public health measures to fight counterfeit medicine market.

Shrivastava SR, Shrivastava PS, Ramasamy J.

Int J Prev Med. 2014 Mar;5(3):370-1. No abstract available.

8.

Impacts of international sanctions on Iranian pharmaceutical market.

Cheraghali AM.

Daru. 2013 Jul 31;21(1):64. doi: 10.1186/2008-2231-21-64.

9.
10.

Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugs.

Mbinze JK, Lebrun P, Debrus B, Dispas A, Kalenda N, Mavar Tayey Mbay J, Schofield T, Boulanger B, Rozet E, Hubert P, Marini RD.

J Chromatogr A. 2012 Nov 9;1263:113-24. doi: 10.1016/j.chroma.2012.09.038. Epub 2012 Sep 20.

PMID:
23046622
11.

Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010.

Kaplan WA, Ritz LS, Vitello M, Wirtz VJ.

Health Policy. 2012 Aug;106(3):211-24. doi: 10.1016/j.healthpol.2012.04.015. Epub 2012 Jun 12. Review.

PMID:
22694970
12.

[Risk sharing methods in middle income countries].

Inotai A, Kaló Z.

Acta Pharm Hung. 2012;82(1):43-52. Review. Hungarian.

PMID:
22570986
13.

Access to essential medicines for sexual and reproductive health care: the role of the pharmaceutical industry and international regulation.

Cottingham J, Berer M.

Reprod Health Matters. 2011 Nov;19(38):69-84. doi: 10.1016/S0968-8080(11)38573-4.

PMID:
22118143
14.

Assessing the problem of counterfeit medications in the United Kingdom.

Jackson G, Patel S, Khan S.

Int J Clin Pract. 2012 Mar;66(3):241-50. doi: 10.1111/j.1742-1241.2011.02826.x. Epub 2011 Nov 9. Review.

PMID:
22070229
15.

Where do pharmaceuticals on the market originate? An analysis of the informal drug supply in Cotonou, Benin.

Baxerres C, Le Hesran JY.

Soc Sci Med. 2011 Oct;73(8):1249-56. doi: 10.1016/j.socscimed.2011.03.050. Epub 2011 Aug 5.

PMID:
21962151
16.

Does the market share of generic medicines influence the price level?: a European analysis.

Dylst P, Simoens S.

Pharmacoeconomics. 2011 Oct;29(10):875-82. doi: 10.2165/11585970-000000000-00000.

PMID:
21797288
17.

[Counterfeit drugs as a gobal threat to health].

Golocorbin Kon S, Mikov M.

Med Pregl. 2011 May-Jun;64(5-6):285-90. Review. Serbian.

PMID:
21789919
18.

Making health markets work better for poor people: the case of informal providers.

Bloom G, Standing H, Lucas H, Bhuiya A, Oladepo O, Peters DH.

Health Policy Plan. 2011 Jul;26 Suppl 1:i45-52. doi: 10.1093/heapol/czr025.

19.

Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines.

Mackintosh M, Chaudhuri S, Mujinja PG.

Global Health. 2011 Feb 28;7:4. doi: 10.1186/1744-8603-7-4.

20.

Greece: Health system review.

Economou C.

Health Syst Transit. 2010;12(7):1-177, xv-xvi.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk